September 2019

CUTISS AG is present with a booth at the EBA 2019 in Helsinki from September 4th – 7th. Soon you’ll find more information about the congress here. To stay tuned, subscribe our newsletter:


August 2019

Interview with Daniela Marino on CNN Money Switzerland

watch >

CUTISS AG and CSEM have been awarded a grant of more than CHF 800’000 by Innosuisse to develop the first-ever automated machine to bioengineer personalised skin grafts for therapy! 

>read press release

July 2019

Another milestone reached: Publication of Phase I Clinical Trial Data of denovoSkin!

read more >

“Fehler akzeptiern und daraus lernen” – CUTISS company presentation on Startup Valley

read more >

June 2019

denovoFix was developed as part of the bachelor thesis of Ms. Astrid Welti and in cooperation with the Zurich University of the Arts (ZHdK).

The patient is taken a small skin sample (biopsy), which is sent to the laboratory. This must be treated with the utmost care. denovoFix protects the biopsy from contamination, shreds it and transfers it to the machine via fluid connection for standardized production of the skin graft. A closed, sterile process is guaranteed.

March 2019

“The B round will need to provide 30-40 million CHF to support the market access.”

Interview with Daniela Marino on

read more >  

December 2018

Forbes – “Cutiss: la peau sur-mesure”

read more > – “Sizilianerin züchtet in Zürich personalisiertes Hauttransplantat”

read more >  

September 2018

CUTISS AG receives SME Instrument Grant for 2.5 Million Euros to automate.


CUTISS AG is TOP5 Swiss start up 2018! What a jump!  

read more >

June 2018

Press release: CUTISS AG raises 7.255.000 CHF in a series A financing round.   

read more >

April 2018

An interview about CUTISS AG with Daniela Marino in the «Tagesanzeiger» 

read more >


CUTISS AG is among the 10 Swiss Venture Leaders that will fly to Boston!

read more >


February 2018

CUTISS AG receives Swissmedic approval to commence phase II denovoSkin™ trial for reconstructive surgery in adults and children.


November 2017

Press release: CUTISS AG has been awarded with the prestigious CTI Start up Label

read more >

Press release: CUTISS AG receives Swissmedic approval to commence Phase IIb denovoSkin™ Trials in burns in adults and children.

read more >

September 2017

CUTISS AG is top 34 Swiss start up 2017! What a great entrance in the ranking!

read more >

Press release: CUTISS AG raises CHF 1 Million in a Seed Financing to advance Personalized Skin Graft Technologies


August 2017

NZZ article about CUTISS AG completing seed round 

read more >

July 2017

CUTISS AG among the TOP 100 start ups in Switzerland

read more >

June 2017

denovoSkin, a project by CUTISS AG at ETH Industry day 2017

read more >

May 2017


read more >

October 2016